Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.

Biotechnology

Achelios Therapeutics

Achelios Therapeutics' headquarters in Chapel Hill, NC, United States

Crist J. Frangakis

John Fort

Wade Ficken

James L. Yeager

Mike S. Fox

Hans-Christoph Diener

Jon Saxe

Jerry Rosenblatt

Paul M Russo

Ru-Rong Ji

Description

People (2)

Crist J. Frangakis

John Fort

Jobs